{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:25:28Z","timestamp":1792801528317,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T00:00:00Z","timestamp":1500076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T00:00:00Z","timestamp":1500076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U10 NS053369"],"award-info":[{"award-number":["U10 NS053369"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U10 NS044501"],"award-info":[{"award-number":["U10 NS044501"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS043127"],"award-info":[{"award-number":["U01NS043127"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00415-017-8562-4","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T03:23:23Z","timestamp":1500089003000},"page":"1746-1753","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Predictors of weight loss in early treated Parkinson\u2019s disease from the NET-PD LS-1 cohort"],"prefix":"10.1007","volume":"264","author":[{"name":"on behalf of the NINDS NET-PD Investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Wills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruosha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,15]]},"reference":[{"issue":"5","key":"8562_CR1","doi-asserted-by":"publisher","first-page":"e0124541","DOI":"10.1371\/journal.pone.0124541","volume":"10","author":"U Akbar","year":"2015","unstructured":"Akbar U, He Y, Dai Y, Hack N, Malaty I, McFarland NR et al (2015) Weight loss and impact on quality of life in Parkinson\u2019s disease. PLoS One 10(5):e0124541","journal-title":"PLoS One"},{"issue":"3","key":"8562_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jamaneurol.2015.4265","volume":"73","author":"AM Wills","year":"2016","unstructured":"Wills AM, Perez A, Wang J, Su X, Morgan J, Rajan SS et al (2016) Association between change in body mass index, unified Parkinson\u2019s disease rating scale scores, and survival among persons with Parkinson disease: secondary analysis of longitudinal data from NINDS Exploratory Trials in Parkinson Disease Long-term Study 1. JAMA Neurol 73(3):321\u2013328","journal-title":"JAMA Neurol"},{"issue":"11","key":"8562_CR3","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/mds.21068","volume":"21","author":"CG Bachmann","year":"2006","unstructured":"Bachmann CG, Trenkwalder C (2006) Body weight in patients with Parkinson\u2019s disease. Mov Disord 21(11):1824\u20131830","journal-title":"Mov Disord"},{"issue":"2","key":"8562_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF02251202","volume":"5","author":"HS Markus","year":"1993","unstructured":"Markus HS, Tomkins AM, Stern GM (1993) Increased prevalence of undernutrition in Parkinson\u2019s disease and its relationship to clinical disease parameters. J Neural Transm Parkinson\u2019s Dis Dement Sect 5(2):117\u2013125","journal-title":"J Neural Transm Parkinson\u2019s Dis Dement Sect"},{"issue":"3","key":"8562_CR5","doi-asserted-by":"publisher","first-page":"e57986","DOI":"10.1371\/journal.pone.0057986","volume":"8","author":"JM Sheard","year":"2013","unstructured":"Sheard JM, Ash S, Mellick GD, Silburn PA, Kerr GK (2013) Markers of disease severity are associated with malnutrition in Parkinson\u2019s disease. PLoS One 8(3):e57986","journal-title":"PLoS One"},{"issue":"7","key":"8562_CR6","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/mds.20837","volume":"21","author":"EY Uc","year":"2006","unstructured":"Uc EY, Struck LK, Rodnitzky RL, Zimmerman B, Dobson J, Evans WJ (2006) Predictors of weight loss in Parkinson\u2019s disease. Mov Disord 21(7):930\u2013936","journal-title":"Mov Disord"},{"issue":"12","key":"8562_CR7","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/mds.25175","volume":"27","author":"JJ Elm","year":"2012","unstructured":"Elm JJ (2012) Design innovations and baseline findings in a long-term Parkinson\u2019s trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson\u2019s Disease Long-term Study-1. Mov Disord 27(12):1513\u20131521","journal-title":"Mov Disord"},{"issue":"6","key":"8562_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1001\/jama.2015.120","volume":"313","author":"K Kieburtz","year":"2015","unstructured":"Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW et al (2015) Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. JAMA 313(6):584\u2013593","journal-title":"JAMA"},{"key":"8562_CR9","doi-asserted-by":"crossref","unstructured":"P\u00e9rez A, Tilley BC (2015) Conduct of stroke-related clinical trials. In: Grotta et al (eds) Stroke: Pathophysiology, diagnosis, and management, 6th edn, Elsevier\u00a0","DOI":"10.1016\/B978-0-323-29544-4.00063-3"},{"issue":"9","key":"8562_CR10","first-page":"718","volume":"89","author":"HL Gaddey","year":"2014","unstructured":"Gaddey HL, Holder K (2014) Unintentional weight loss in older adults. Am Fam Phys 89(9):718\u2013722","journal-title":"Am Fam Phys"},{"key":"8562_CR11","unstructured":"Evans A, Gupta R (2017) Approach to the patient with unintentional weight loss. \n                    https:\/\/www.uptodate.com\/contents\/approach-to-the-patient-with-unintentional-weight-loss?source=related_link\n                    \n                  . Accessed 6 July 2017"},{"issue":"5","key":"8562_CR12","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/ana.10577","volume":"53","author":"H Chen","year":"2003","unstructured":"Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A (2003) Weight loss in Parkinson\u2019s disease. Ann Neurol 53(5):676\u2013679","journal-title":"Ann Neurol"},{"issue":"6","key":"8562_CR13","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.clnu.2013.12.012","volume":"33","author":"M Vikdahl","year":"2014","unstructured":"Vikdahl M, Carlsson M, Linder J, Forsgren L, Haglin L (2014) Weight gain and increased central obesity in the early phase of Parkinson\u2019s disease. Clin Nutr 33(6):1132\u20131139","journal-title":"Clin Nutr"},{"issue":"2","key":"8562_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1017\/S0007114512004941","volume":"110","author":"M Barichella","year":"2013","unstructured":"Barichella M, Cereda E, Madio C, Iorio L, Pusani C, Cancello R et al (2013) Nutritional risk and gastrointestinal dysautonomia symptoms in Parkinson\u2019s disease outpatients hospitalised on a scheduled basis. Br J Nutr 110(2):347\u2013353","journal-title":"Br J Nutr"},{"issue":"1","key":"8562_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.48.1.88","volume":"48","author":"MJ Toth","year":"1997","unstructured":"Toth MJ, Fishman PS, Poehlman ET (1997) Free-living daily energy expenditure in patients with Parkinson\u2019s disease. Neurology 48(1):88\u201391","journal-title":"Neurology"},{"issue":"2","key":"8562_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/mds.10630","volume":"19","author":"F Macia","year":"2004","unstructured":"Macia F, Perlemoine C, Coman I, Guehl D, Burbaud P, Cuny E et al (2004) Parkinson\u2019s disease patients with bilateral subthalamic deep brain stimulation gain weight. Mov Disord 19(2):206\u2013212","journal-title":"Mov Disord"},{"issue":"8","key":"8562_CR17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1468-1331.2009.02617.x","volume":"16","author":"CG Bachmann","year":"2009","unstructured":"Bachmann CG, Zapf A, Brunner E, Trenkwalder C (2009) Dopaminergic treatment is associated with decreased body weight in patients with Parkinson\u2019s disease and dyskinesias. Eur J Neurol 16(8):895\u2013901","journal-title":"Eur J Neurol"},{"issue":"8","key":"8562_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.parkreldis.2012.05.004","volume":"18","author":"JC Sharma","year":"2012","unstructured":"Sharma JC, Turton J (2012) Olfaction, dyskinesia and profile of weight change in Parkinson\u2019s disease: identifying neurodegenerative phenotypes. Parkinsonism Relat Disord 18(8):964\u2013970","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"8562_CR19","doi-asserted-by":"publisher","first-page":"e00616","DOI":"10.1002\/brb3.616","volume":"7","author":"A Tsuge","year":"2017","unstructured":"Tsuge A, Kaneko S, Wate R, Oki M, Nagashima M, Asayama S et al (2017) Weight loss in the early stage of progressive supranuclear palsy. Brain behav 7(2):e00616","journal-title":"Brain behav"},{"issue":"5","key":"8562_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.parkreldis.2015.02.005","volume":"21","author":"H Park","year":"2015","unstructured":"Park H, Lee JY, Shin CM, Kim JM, Kim TJ, Kim JW (2015) Characterization of gastrointestinal disorders in patients with parkinsonian syndromes. Parkinsonism Relat Disord 21(5):455\u2013460","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-017-8562-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8562-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8562-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T13:01:36Z","timestamp":1589634096000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-017-8562-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,15]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["8562"],"URL":"https:\/\/doi.org\/10.1007\/s00415-017-8562-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,15]]},"assertion":[{"value":"3 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Wills has received research support from the NIH, the MDA, ALSA, has consulting agreements with Accordant, a CVS\/Caremark disease management company and with Sage Bionetworks and has participated in clinical trials funded by Merck, Acorda and Pfizer. Dr. P\u00e9rez reports NIH grants and Texas Department of State and Human Services grants. Ruosha Li and Xuehan Ren report grants from the NIH. Dr. Boyd served as a consultant and\/or scientific advisor for AbbVie, Auspex, Teva, Lundbeck, Chronos Therapeutics, Neurocrine, and Medical Education Resources. He has received research support from the Michael J. Fox Foundation for Parkinson Research, NIH\/NINDS, Auspex, Biotie, CHDI Foundation, Vaccinex, Teva, AbbVie, NeuroDerm, and Roche.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosure"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}